Lincoln Pharmaceuticals Ltd News

Lincoln Pharma Q1 results: Profit up 17% to ₹28 cr, share jumps 8.5%

Lincoln Pharmaceuticals on Thursday reported a nearly 17 per cent growth in net profit to Rs 27.70 crore for the April-June quarter as compared to Rs 23.69 crore in the same quarter of the last fiscal. Total income rose by 7.3 per cent to Rs 169.34 crore in the first quarter of FY26 compared to Rs 157.69 crore in the year-ago period, the company said in a statement. "EBITDA for Q1 FY26 was reported at Rs 39.08 crore as compared to EBITDA of Rs 33.14 crore in Q1 FY25, growth of 17.92 per cent Y-o-Y, the statement said. The company is targeting a revenue of Rs 1,000 crore within the next three years, driven by business expansion into high-value product lines and entry into new markets, Lincoln Pharmaceuticals Managing Director Mahendra Patel said. This goal is part of a broader strategy to achieve a 15-18 per cent annual growth rate, driven by strong performance in the cardiac, diabetic, dermatology, and ENT segments, Patel added. During the first quarter, the company started its bu